EconStor >
Stockholm School of Economics >
EFI - The Economic Research Institute, Stockholm School of Economics >
SSE/EFI Working Paper Series in Economics and Finance, EFI - The Economic Research Institute, Stockholm School of Economics >

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10419/56346
  

Full metadata record

DC FieldValueLanguage
dc.contributor.authorEkelund, Matsen_US
dc.date.accessioned2012-02-29en_US
dc.date.accessioned2012-03-28T13:10:51Z-
dc.date.available2012-03-28T13:10:51Z-
dc.date.issued2000en_US
dc.identifier.urihttp://hdl.handle.net/10419/56346-
dc.language.isosween_US
dc.publisherEkonomiska Forskningsinst. Stockholmen_US
dc.relation.ispartofseriesSSE/EFI Working Paper Series in Economics and Finance 404en_US
dc.subject.jelH51en_US
dc.subject.jelI18en_US
dc.subject.ddc330en_US
dc.titleNya förutsättningar för svensk läkemedelsmarknaden_US
dc.typeWorking Paperen_US
dc.identifier.ppn687679990en_US
dc.rightshttp://www.econstor.eu/dspace/Nutzungsbedingungenen_US
Appears in Collections:SSE/EFI Working Paper Series in Economics and Finance, EFI - The Economic Research Institute, Stockholm School of Economics

Files in This Item:
File Description SizeFormat
687679990.pdf101.65 kBAdobe PDF
No. of Downloads: Counter Stats
Show simple item record
Download bibliographical data as: BibTeX

Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.